chronic obstructive pulmonary disease copd heterogeneous disease understood forced expiratory volume second used diagnosis staging copd wide acceptance crude measure insensitive change shorter periods time evaluation copd longitudinally identify predictive surrogate eclipse longitudinal study specific aims NUMBER definition clinically relevant copd subtypes NUMBER identification parameters predict disease progression subtypes NUMBER examination biomarkers correlate copd subtypes predict disease progression NUMBER identification novel genetic factors biomarkers correlate clinically relevant copd subtypes predict disease progression eclipse plans recruit NUMBER copd subjects global initiative chronic obstructive lung disease categories NUMBER smoking NUMBER nonsmoking control subjects study procedures performed baseline NUMBER months NUMBER months NUMBER months assessments include pulmonary function measurements spirometry impulse oscillometry plethysmography chest computed tomography biomarker measurement blood sputum urine exhaled breath condensate health outcomes body impedance resting oxygen saturation walking distance evaluation copd longitudinally identify predictive surrogate largest study attempting better subtypes chronic obstructive pulmonary disease defining predictive markers progression end points NUMBER yr ii iv NUMBER min end points